Starget Pharma

Ramat HaSharon, Israel · Founded 2019 · Privately Held (backing)

Operator of a biotechnology company intended to specialize in the diagnosis and targeted treatment of cancer using targeted radioactive radiation. Starget Pharma is based in Ramat HaSharon, Israel and was founded in 2019. It has raised $37.3 million across 1 recorded round; the latest was a $16.4 million early-stage round in Jan 2026.

Last price · $/share
—
Implied valuation
—
Total raised
$37.3M
Last round
Early Stage VC
Jan 2026
How much has Starget Pharma raised?
$37.3Macross 1 recorded rounds · Jan 2026 – Jan 2026

Most recently, Starget Pharma raised $16.4M in its Early Stage VC (Jan 2026).

Free account
More of Starget Pharma with a free account
  • ·Watch Starget Pharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Starget Pharma round by round

1 rounds
Jan 2026Early Stage VC$16.4MSEC filing▮
29 investors participated

How much has Starget Pharma raised?

Starget Pharma has raised $37.3 million in total; 1 of its rounds is on record. The largest on record was a $16.4 million early-stage round in Jan 2026.

Starget Pharma investors

8 investors are on record for Starget Pharma, including Louisiana Economic Development, 2b AHEAD Ventures, ARC Innovation Center and BRF(Shreveport). The early-stage round in Jan 2026 drew 29 investors.

For fundraisers
Raising for a company like Starget Pharma?

8 investors have backed Starget Pharma.

See all 8 investors →

Frequently asked about Starget Pharma

How much has Starget Pharma raised?
Starget Pharma has raised $37.3M in total across 1 recorded funding rounds.
When was Starget Pharma's last funding round?
Starget Pharma's most recent recorded round was Early Stage VC in Jan 2026, raising $16.4M.